Eyeworld

Register today! Friday, April 17 – monday, April 20, 2015 Learn from the experts! Attend the EyeWorld Symposia for additional CME and an opportunity to advance your surgical and clinical knowledge during breakfast, lunch, and dinner symposia. These activities are approved for AMA PRA Category 1 Credits. TM Friday, April 17 Innovating Advanced Treatments for Your Glaucoma Patients: Diagnostics, Novel Therapies, and Surgical Options Supported by educational grants from Aerie, Alcon Laboratories Inc., and Glaukos Additional grants pending. 6:30 – 7:00 Am Registration (and breakfast) 7:00 – 8:00 Am Program Program Chair: Richard A. Lewis, mD Educational Objectives • Describe the issue of treatment compliance in the management of glaucoma and its impact on patient outcomes; • Assess the impact of novel pharmaceutical options on treatment compliance among glaucoma patients and their corresponding effect on treatmen outcomes; and • Identify the latest scientific information on current research and evolving techniques in MIGS, to maximize the outcomes in a practice. This live educational activity is approved for 1 AMA PRA Category 1 Credits TM . Target Audience These educational activities are intended for ophthalmologists. Accreditation Statement These activities have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society of Cataract and Refractive Surgery (ASCRS) and EyeWorld newsmagazine. ASCRS is accredited by the ACCME to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality, and scientific integrity of this CME activity. Designation Statement The American Society of Cataract and Refractive Surgery designates these live educational activities for a maximum of AMA PRA Category 1 Credits™ as noted within information for each of the activities above. Physicians should claim only credit commensurate with the extent of their participation in these activities. All CME activities approved for AMA PRA Category 1 Credit™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in these CME activities are eligible for AMA PRA Categ ory 1 Credit™. Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits. Notice of Off-Label Use Presentations These programs may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he/she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical edu- cation. Inclusion of any presentation in these programs, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques pre- sented. ADA/Special Accommodations ASCRS fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also requires ADA compliance from its contracted vendors and facilities. Any participant in these educational programs who require special accommodation or services should contact an ASCRS or EyeWorld staff member onsite.

• Cover